Curreio

Curreio is a Tokyo-based biotechnology company specializing in structure-based drug discovery (SBDD) leveraging advanced Cryo-Electron Microscopy (Cryo-EM) technology. The company focuses on challenging drug targets, such as membrane proteins, GPCRs, and large molecular complexes, which are difficult to analyze using traditional X-ray crystallography. Curreio operates through a dual business model, providing high-resolution structural analysis services to pharmaceutical partners while simultaneously advancing its internal pipeline of small molecule therapeutics. By integrating structural biology with computational chemistry, Curreio aims to accelerate the development of novel treatments for various diseases.